| Literature DB >> 32195188 |
Xiaomeng Liu1,2, Yueqiang Liang3, Jian Zhu4, Gang Yu5, Yanyan Yu6, Qiang Cao7, X Allen Li8, Baosheng Li2.
Abstract
Purpose: The purpose of this work was to propose an online replanning algorithm, named intensity field projection (IFP), that directly adjusts intensity distributions for each beam based on the deformation of structures. IFP can be implemented within a reasonably acceptable time frame. Methods and Materials: The online replanning method is based on the gradient-based free form deformation (GFFD) algorithm, which we have previously proposed. The method involves the following steps: The planning computed tomography (CT) and cone-beam CT image are registered to generate a three-dimensional (3-D) deformation field. According to the 3-D deformation field, the registered image and a new delineation are generated. The two-dimensional (2-D) deformation field of ray intensity in each beam direction is determined based on the 3-D deformation field in the region of interest. The 2-D ray intensity distribution in the corresponding beam direction is deformed to generate a new 2-D ray intensity distribution. According to the new 2-D ray intensity distribution, corresponding multi-leaf collimator (MLC), and jaw motion data are generated. The feasibility and advantages of our method have been demonstrated in 20 lung cancer intensity modulated radiation therapy (IMRT) cases.Entities:
Keywords: adaptive radiotherapy; deformable image registration; image guided radiotherapy; interfractional variations; online replanning
Year: 2020 PMID: 32195188 PMCID: PMC7063069 DOI: 10.3389/fonc.2020.00287
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
Figure 1Flowchart of the IFP methodology.
Figure 2Schematic diagram of obtaining the two-dimensional deformation vector. V represents the ROI set by the X, Y, and Z axes of the coordinate system. The arrows in the ROI V represent the 3D deformation vector “” of each pixel in the ROI.
Figure 3Explanation of how to obtain the ray projection on the isocentric plane. S is an isocenter plane, and S is parallel to the plane in which the coordinate system X and Y axis are located. Each point on S (i.e., the intersection of the ray R and the isocenter plane S) represents a ray. The intensity of each ray is I, and there is a 2-D ray intensity distribution I (x, y) on the isocenter plane.
Characteristics of the patients.
| Male | 16 |
| Female | 4 |
| Left | 13 |
| Right | 7 |
| IB | 3 |
| IIA | 2 |
| IIB | 3 |
| IIIA | 8 |
| IIIB | 4 |
Comparison between the IFP and other algorithms.
| SAM+SWO ( | Morphing beam segment shapes to match the new location and shape of the target; Optimizing the new segment weight | Semi-automated | Within 10 min | Two prostate canses; one pancreas case | V100% = 98% for GTV | Requires the contours of important structures to be drawn online |
| Method by Li et al. ( | Iteratively adjusting voxel-weighting factors in an objective function under the guidance of DVHs | Automated | 30 s | Three head-and- neck cases | D99% = 58–69 Gy, V95% = 101–102% for PTV70; max cord dose = 13–24 Gy, max brainstem dose = 13–19 Gy, left mean parotid dose = 8–14 Gy, right mean parotid dose = 15–20 Gy | The achievability of the original DVHs in the new patient geometry will impact the efficacy of the algorithm; neglects the spatial dose information |
| GM ( | Capture the dose gradients from the original plan; Proceeds with a replanning optimization process aiming to maintain the originally achieved dose gradients on the anatomy of the day based on the daily image | Automated | Within 5 min | Five prostate and Five pancreas casess | Prostate: D95% = 75.6 Gy, mean bladder dose = 23.0 ± 9.9 Gy, max femoral-head dose(left) = 39.8 ± 7.7 Gy, max femoral-head dose(right) = 38.1 ± 9.9 Gy; Pancreas: D95% = 50.4 Gy, mean duodenum dose = 21.9 ± 4.7 Gy, mean stomach dose = 4.0 ± 2.9 Gy, mean liver dose = 3.1 ± 2.0 Gy, max cord dose = 20.7 ± 7.4 Gy | Not suitable for the case of large OAR deformation |
| Method by Zarepisheh et al. ( | Creates a treatment plan guided by the DVH curves of a reference plan that contains information on the clinician-approved dose-volume trade-offs among different targets/organs and among different portions of a DVH curve for an organ | Automated | ~ 10 s | Two prostate case; one head-and-neck case | Prostate: D95% = 71 Gy, max femoral-head dose = 30 Gy, max bladder dose = 75 Gy, max rectum dose = 78 Gy; Head-and-neck: D95% = 70 Gy for PTV70, max cord dose = 36 Gy, max brainstem dose = 30 Gy | Only pick the DVH to guide the process while other clinical related factors were ignored |
| IFP | Realizing adaptive correction by projecting a 3-D vector field into a 2-D vector field for deformation of intensity distribution | Automated | Approximately 3 min | Twenty lung cases | V100% = 100%, D95% = 60 Gy for CTV; mean total lung doses = 12.2 Gy, mean heart doses = 4.7 Gy, max cord dose = 38.5 Gy | Not sensitive to the site with low gray-gradient |
Average dosimetric parameters for the three scenarios (original plan, repositioning plan, and IFP plan) of the lung cases.
| CTV | D95 (Gy) | 44.0 | 58.5 | 60.3 | 0.49 | <0.01 | <0.01 |
| CTV | V100% | 82.6 | 86.7 | 100 | 0.17 | <0.01 | <0.01 |
| CTV | HI (D5/D95) | 1.3 | 1.2 | 1.1 | 0.20 | <0.01 | <0.01 |
| Cord | Max (Gy) | 38.6 | 38.5 | 38.5 | 0.76 | 0.95 | 0.93 |
| Total lung | Mean (Gy) | 12.4 | 12.6 | 12.2 | <0.01 | <0.01 | <0.01 |
| Total lung | V5 (Gy) | 45.1 | 44.8 | 44.6 | <0.01 | <0.01 | 0.01 |
| Total lung | V20 (Gy) | 20.0 | 19.7 | 20.2 | 0.94 | 0.4 | 0.15 |
| L-lung | Mean (Gy) | 9.2 | 9.3 | 9.0 | 0.81 | <0.01 | <0.01 |
| L-lung | V5 (Gy) | 40.1 | 39.4 | 39.3 | 0.01 | <0.01 | <0.01 |
| L-lung | V20 (Gy) | 13.4 | 12.9 | 13.7 | 0.02 | 0.79 | 0.55 |
| R-lung | Mean (Gy) | 16.6 | 16.5 | 16.0 | 0.67 | 0.09 | 0.06 |
| R-lung | V5 (Gy) | 51.8 | 52.6 | 53.4 | 0.35 | 0.14 | 0.12 |
| R-lung | V20 (Gy) | 29.1 | 29.2 | 29.4 | 0.27 | 0.65 | 0.87 |
| Heart | Mean (Gy) | 5.6 | 5.4 | 4.7 | 0.05 | <0.01 | <0.01 |
| Heart | V30 (Gy) | 14.2 | 15.0 | 12.7 | <0.01 | <0.01 | <0.01 |
CTV, clinical target volume; D95, the doses with which 95% of the CTV was covered; V100%, the percentage of the CTV receiving the prescribed dose; HI, homogeneity index; V5, the percentages of the normalized volume of OARs receiving 5 Gy; V20, the percentages of the normalized volume of OARs receiving 20 Gy; V30, the percentages of the normalized volume of OARs receiving 30 Gy.
Figure 4Comparison of the target volume in the representative CT slice. Comparison of the target volume in the representative CT slice obtained on the CT-plan (A), the corrected CT of fraction 6 (B) and the corrected CT (C) of fraction 16, and DVH curves comparison for the fraction 6 (D) and fraction 16 (E) for patient 1. The dotted, dashes, and solid curves represent the original, IFP and the repositioning plans, respectively.
Figure 5Comparison of representative CT slices. Comparison of representative CT slices obtained on the planning CT (A), the CBCT before shift couch (B), the CBCT after shift couch (C), and the corrected CT image (D) as well as DVH curves comparison (E) of the same fraction for a lung cancer patient. The dotted, dashes, and solid curves represent the original, IFP and the repositioning plans, respectively.